Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 16 of 42 for:    LENALIDOMIDE AND Leukemia AND SLL

Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02200848
Recruitment Status : Terminated (Recruitment difficulties and toxicity)
First Posted : July 25, 2014
Last Update Posted : January 12, 2018
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 27, 2017
Actual Study Completion Date : August 1, 2017